Gene Expression in Burkitt’s Lymphoma Cells. In: Becker Y, Darai G, editors. Pathogenicity of Human Herpesviruses due to Specific Pathogenicity Genes. Berlin: Springer Berlin Heidelberg; 1994. pp. 283-97. [DOI: 10.1007/978-3-642-85004-2_17]

Epstein-Barr virus genes and cancer cells

Human B lymphocytes infected with Epstein-Barr virus (EBV) express 11 viral genes, of which six are essential for efficient transformation. The protein products of these genes appear to cause cell growth by modifying cell signal transduction pathways. For example, EBNA-2 mimics the Notch 1 pathway and LMP-1 interacts with the signalling from CD40/CD40-L, which promotes growth in normal B cells. In the human cancers linked to EBV, most of the viral transforming genes are not expressed. It is likely that growth of these cells is controlled by a combination of the EBV genes whose expression continues with altered cell proto-oncogenes and tumour suppressor genes, but other explanations of the role of EBV in cancer cells are also possible. The presence of the virus in the tumour cells of EBV-associated cancers constitutes a potentially useful tumour specific marker that might be used to direct therapy to the tumour cells.